As part of its $320 million Series B round, NantHealth has closed $250 million in additional funding from one of the world’s largest sovereign wealth funds, the Kuwait Investment Authority (KIA), to enable better patient care and reduced costs. The new investor joins Verizon, Celgene, Blackberry and Blackstone, all of which have already pledged their money to support NantHealth’s vision.
NantHealth enables providers to utilize big data to make real-time, evidence-based decisions.The company also announced the expansion of its leadership team. Steve Curd has been named COO, and Laura Beggrow – Executive Vice President, Commercialization. In its previous roles, Curd was COO of WebMD, CIO of United Healthcare and CEO of VantageMed; whereas Beggrow served as President of Strand Diagnostics and Vice President of US Sales and Marketing at Genomics Health. Additionally, Scott Holbrook, co-founder of KLAS, will join NantHealth’s Board of Directors.
“Our new leadership team has the expertise, relationships and deep knowledge necessary to drive NantHealth forward and make our vision of transforming the healthcare system and delivering truly personalized medicine a reality,” said Patrick Soon-Shiong, M.D., founder and CEO of NantHealth. “Their addition to the company along with KIA’s continued investments show the strength and confidence in NantHealth’s ability to deliver on 21st century medicine and value-based population health care.”
NantHealth combines science and technology in a single healthcare management system that enables providers to utilize big data to make real-time, evidence-based decisions. The company’s robust platform of tools and solutions provides access to genomic and proteomic data at the patient level to analyze the root cause of disease, all available information about medicines and clinical trials, up-to-date scientific research, and the connectivity and data management software and infrastructure needed to make the information actionable.